GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » PS Ratio

Pediatrix Medical Group (Pediatrix Medical Group) PS Ratio

: 0.37 (As of Today)
View and export this data going back to 1959. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Pediatrix Medical Group's share price is $9.05. Pediatrix Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $24.15. Hence, Pediatrix Medical Group's PS Ratio for today is 0.37.

Good Sign:

Pediatrix Medical Group Inc stock PS Ratio (=0.36) is close to 10-year low of 0.34

The historical rank and industry rank for Pediatrix Medical Group's PS Ratio or its related term are showing as below:

MD' s PS Ratio Range Over the Past 10 Years
Min: 0.34   Med: 1.45   Max: 3.16
Current: 0.36

During the past 13 years, Pediatrix Medical Group's highest PS Ratio was 3.16. The lowest was 0.34. And the median was 1.45.

MD's PS Ratio is ranked better than
84.1% of 648 companies
in the Healthcare Providers & Services industry
Industry Median: 1.515 vs MD: 0.36

Pediatrix Medical Group's Revenue per Sharefor the three months ended in Dec. 2023 was $6.02. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $24.15.

During the past 12 months, the average Revenue per Share Growth Rate of Pediatrix Medical Group was 3.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was -1.70% per year.

During the past 13 years, Pediatrix Medical Group's highest 3-Year average Revenue per Share Growth Rate was 72.80% per year. The lowest was -15.90% per year. And the median was 13.10% per year.

Back to Basics: PS Ratio


Pediatrix Medical Group PS Ratio Historical Data

The historical data trend for Pediatrix Medical Group's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.18 1.22 0.63 0.38

Pediatrix Medical Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.63 0.59 0.52 0.38

Competitive Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pediatrix Medical Group PS Ratio Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's PS Ratio falls into.



Pediatrix Medical Group PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Pediatrix Medical Group's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=9.05/24.151
=0.37

Pediatrix Medical Group's Share Price of today is $9.05.
Pediatrix Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.15.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Pediatrix Medical Group  (NYSE:MD) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Pediatrix Medical Group PS Ratio Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Traded in Other Exchanges
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.
Executives
James D Swift officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E officer: EVP Chief ERM/Legal Ops Off 1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan director, officer: Chief Executive Officer 7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis director 11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young director C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood officer: EVP, Natl & Market Operations 1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky director 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel director, officer: PRES. & CHIEF EXEC. OFFICER 1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia officer: Principal Accounting Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson officer: Pres., PDX & OBX Medical Group C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards officer: EVP, Chief Financial Officer 7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano officer: Sr.VP,General Counsel & Secy. 1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos officer: EVP Chf Strategy & Growth Offi MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323

Pediatrix Medical Group (Pediatrix Medical Group) Headlines